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Abstract
Kru ¨ppel-like factor 8 (KLF8) plays important role in cell cycle and oncogenic transformation. Here we report the mechanisms
by which KLF8 crosstalks with Wnt/b-catenin signaling pathway and regulates hepatocellular carcinoma (HCC) cells
proliferation. We show that overexpression of KLF8 and nucleus accumulation of b-catenin in the human HCC samples are
positively correlated. More importantly, KLF8 protein levels plus nucleus accumulation of b-catenin levels were significantly
elevated in high-grade HCC compared to low-grade HCC. Using HCC HepG2 cells we find that, on the one hand both
protein and mRNA of KLF8 are up-regulated under Wnt3a stimulation, on the other hand overexpression of KLF8 increases
the cytoplasm and nucleus accumulation of b-catenin, recruits p300 to b-catenin/T-cell factor 4 (TCF4) transcription
complex, enhances TOP flash report gene transcription, and induces Wnt/b-catenin signaling target genes c-Myc, cyclin D1
and Axin1 expression. Knockdown of KLF8 using shRNA inhibits Wnt3a induced transcription of TOP flash report gene and
expression of c-Myc, cyclin D1 and Axin1. Knockdown of b-catenin by shRNA rescues the enhanced HepG2 and Hep3B cells
proliferation ability induced by overexpression of KLF8.
Citation: Yang T, Cai S-Y, Zhang J, Lu J-H, Lin C, et al. (2012) Kru ¨ppel-Like Factor 8 Is a New Wnt/Beta-Catenin Signaling Target Gene and Regulator in
Hepatocellular Carcinoma. PLoS ONE 7(6): e39668. doi:10.1371/journal.pone.0039668
Editor: Xin-yuan Guan, The University of Hong Kong, China
Received March 14, 2012; Accepted May 24, 2012; Published June 27, 2012
Copyright:  2012 Yang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by the National Natural Science Foundation for Youths of China (No. 81000166); the National Natural Science Foundation of
China (No. 81172020); the Shanghai Guiding Program of Science and Technology Development Commission Foundation (No. 10411963300); the Shanghai
Program for Excellent Talents in Health System (No. XYQ2011033); and the Shanghai Foundation for Youths of Health Bureau (No. ab8307000-2010-92). The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: fengshensmmu@gmail.com (FS); mengchao_wu@sina.com (MW)
. These authors contributed equally to this work.
Introduction
Canonical Wnt/b-catenin signaling pathway plays essential role
in regulating developmental decision and adult tissue homeostasis.
The key regulatory molecule is b-catenin, which is kept low level in
cytoplasm by its binding to the cytoplasmic tail of E-cadherin and
its degradation through a destruction complex consisting of Axin1,
glycogen synthase kinase-3b (GSK-3b), adenomatous polyposis
coli (APC) and casein kinase Ia (CKIa) in the absence of Wnt
signaling. Activation of canonical Wnt signaling by Wnt binding to
the 7-span transmembrane protein Frizzled (Fz) and the single-
span low-density lipoprotein receptor-related protein (LRP) leads
to inhibition of GSK-3b activity and translocation of b-catenin to
the nucleus, where it interacts with the TCF/lymphoid enhancer
factor (LEF) family of transcription factors for up-regulation of
such target genes as Axin1, c-Myc and cyclin D1 [1]. Various
human cancers including HCC manifest abnormal b-catenin/
TCF/LEF transactivation due to mutations in Wnt/b-catenin
signaling pathway such as b-catenin, APC, axin, etc. [2–7].
KLF8 belongs to the Kru ¨ppel-like factor (KLF) family of
transcription factors, which share homology in their three C2–H2
zinc finger DNA binding domains, play critical role in diverse
processes, including regulation of the cell cycle progression,
oncogenic transformation and cell invasion [8–10]. KLF8 has
been shown to be positively regulated by activation of Focal
Adesion Kinase (FAK) and PI3K/Akt signaling pathway [9,11].
KLF8 has been found over-expressing and playing important roles
in many human malignant tumors [10–12]. Recent investigation
revealed that KLF8 is highly expressed in HCC tissues and
promotes HCC cell proliferation and invasion [13]. However, the
mechanism how KLF8 regulates HCC cell proliferation is still
unknown.
Here, we report that KLF8 is a novel participator in canonical
Wnt/b-catenin signaling pathway. We show that activation of
Wnt/b-catenin signaling increases the expression of KLF8, in the
meanwhile, KLF8 stabilizes b-catenin, binds with b-catenin/
TCF4 complex, enhances Wnt/b-catenin signaling transcription
activation in HCC cells.
Materials and Methods
Cell Cultures, Plasmids, Antibodies and Chemicals
HCC cell lines HepG2 and Hep3B, L Wnt-3A cells and control
L cells, were purchased from American Type Culture Collection
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from ATCC. Wnt-3a conditioned medium and control L cell
medium were harvested and treated HepG2 cells for 4 hours for
western blot assay, 16 hours for qRT-PCR assay and report gene
assay. Human b -catenin shRNA, target sequences: 59-CTGA-
TATTGATGGACAGTA-39, and human KLF8 shRNA plas-
mids, including shRNA1, target sequence: 59-CTGGTCGA-
TATGGATAAACTCA-39, shRNA2, target sequence: 59-
CAGCAGATCTTACATGTCA-39, and shRNA control, target
sequence: TGAGCAGGCGCATGTGCTG-39, were obtained
from Open Biosystems. The plasmid of KLF8 (MHS1010-
98053352) was purchased from Open Biosystems and was
subcloned into pCMV-tag5A vector with c-myc tag. Primary
antibodies to b-catenin and cyclin D1 were purchased from BD
Biosciences. Primary antibodies to a-tubulin and Sp1 were
purchased from Sigma. Anti-c-Myc antibody was purchased from
ATCC. Primary antibodies to KLF-8, Axin1, p300, and TCF4
were purchased from Abcam. Second antibodies anti-mouse IgG-
HRP and anti-rabbit-HRP were purchased from Sigma. MTT
assay reagents were purchased from DingGuo Biotech.
Immunohistochemical Staining
HCC samples were obtained from Eastern Hepatobiliary
Surgery Hospital. 5-mm thick tissues sections were gotten and
dewaxed, endogenous peroxidase was quenched by incubating
with 3% H2O2 in methanol for 30 min. After incubating with
blocking buffer (10% BSA in TBS) at 37uC for 1 hour, tissues
sections were incubated with primary antibodies in TBS contain-
ing 1% BSA at 4uC overnight, followed by incubation with a
horseradish peroxidase anti-rabbit or –mouse IgG antibody. Color
was then developed by incubation with an ImmunoPure Metal
Enhanced Diaminobenzidine (DAB) Substrate kit (Pierce). After
each incubation, tissue sections were washed three times in TBS
over 10 min. Tissue sections were finally counterstained with
hematoxylin.
Immunoblotting and Immunoprecipitation Assay
Cells were washed with ice-cold phosphate buffer saline, pH 7.4
(PBS) and lysed with ice-cold radioimmunoprecipitation assay lysis
buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM sodium
orthovanadate 10 mM sodium fluoride, 1 mM phenylmethylsul-
fonyl fluoride, 2 mg/ml aprotinin, 2 mg/ml leupeptin, 1 mg/ml
pepstatin A, 15 mg/ml benzamidine, 0.5% NP-40, 0.15% bovine
serum albumin and 10% glycerol) at 4uC for 1 hrs. Samples were
centrifuged at 12,000 g for 15 min at 4uC. For subcellular
fractionation, cell-surface, cytoplasmic and nuclear extracts were
prepared using Qproteome Cell Compartment Kit (Qiagen).
Samples were subjected to SDS-PAGE, transferred to PVDF
membranes (Millipore) and detected with appropriate primary
antibodies followed by horseradish peroxidase-conjugated goat
anti-mouse or rabbit IgG. The blotting signals were detected using
SuperSignal West Dura Extended Duration Substrate (Pierce).
Quantitative analyses of immunoblotting signals were obtained via
densitometry analysis using LAS4000 Image Software (Fuji Film).
For immunoprecipitation, 1 mg appropriate antibody was
preincubated with 30 ml slurry of Protein A-agarose beads (GE
Healthcare Life Sciences). Lysates (,1 mg/sample) were incubat-
ed with the antibody-bound Protein A-agarose beads at 4uC
overnight. After extensive washing with the radioimmunoprecip-
itation assay lysis buffer, samples were resuspended in the reducing
SDS sample loading buffer, boiled for 5 min, and subjected to
SDS-PAGE and immunoblotting.
qRT-PCR
Total RNA was extracted using the Absolutely RNA Miniprep
Kit (Stratagene) and reverse transcribed using ThermoScript RT-
PCR System (Invitrogen). The resulting cDNA was used for PCR
using the SYBR-Green Master PCR Mix (Applied Biosystem) in
triplicates. All RT
2 qPCR Primer pairs were purchased from
SABiosciences. PCR and data collection were performed on the
Mx3000 qPCR System (Stratagene). All quantitations were
normalized to an endogenous b-actin control. The relative
quantitation value for each target gene compared to the calibrator
for that target is expressed as 2-(Ct-Cc) (Ct and Cc are the mean
threshold cycle differences after normalizing to b-actin). The
relative expression levels of samples are presented using a semi-log
plot.
Luciferase Reporter Assay
To evaluate b-catenin/TCF-dependent transcriptional activity,
luciferase reporter assay was performed with a pair of luciferase
reporter constructs TOP-FLASH and FOP-FLASH (Upstate
Biotechnology). TOP-FLASH contains three copies of the TCF
binding sites, and FOP-FLASH contains mutated TCF binding
sites. Cells were transiently transfected in triplicate with one of
these luciferase reporters and pCMV-b-galactosidase (Promega)
using Lipofectamine 2000 (Invitrogen). 48 h after transfection,
luciferase activity was determined using the Luciferase Assay
System Kit (Promega). b-galactosidase activity was determined
using the Luminescent b-gal Detection Kit II (BD Clontech) as an
internal control.
Cell Proliferation MTT Assay
Cells including all transfectants were grown in exponential
phase and detached by trypsin treatment. Viable cells
(5610
3 cells/ml) were plated into 96-well tissue culture plates
(100 ml complete medium/well) and cultured at 37uCi n5 %C O 2
atmosphere. At different time points, tetrazolium salt was added
(20 ml per well) and incubated at 37uC for 4 hr. The insoluble blue
formazan product was solubilized by addition of 100 ml/well 10%
SDS/5% isobutanol. The plates were read on a micro-titer plate
reader using a test wavelength of 570 nm and a reference
wavelength of 630 nm.
Statistical Analysis
To compute correlation coefficients of immunostaining scores
between two proteins, Spearman’s rank correlation coefficient was
used. P values of less than 0.05 were considered statistically
significant. All computations were made with R 2.9.0 (www.r-
project.org).
Results
KLF8 Overexpresses in HCC Samples and Stabilizes b-
catenin
We first detected expression pattern of KLF8 protein in human
HCC samples using immunohistochemical analysis, immunoreac-
tivity for KLF8 antigens was seen in 72.3% (47/65) of HCC
samples. We then examined possible correlation of the positive
KLF8 with b-catenin in these 65 cases of HCC by immunohis-
tochemistry assay. Using continuous tissue sectioning, we found
that 82.98% (39/47) of KLF8 positive HCC samples showed
cytoplasmic and nuclear b-catenin accumulation, compared to
only 38.89% (7/18) KLF8 negative HCC samples showed
cytoplasmic and nuclear b-catenin accumulation (p,0.05,
Fig. 1A, B). In HCC HepG2 cells, we found that, when we
KLF8 Regulates Wnt Signaling in HCC
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cytoplasmic and nuclear b-catenin increased, but the total b-
catenin protein and mRNA level did not change (Fig. 1C, D).
These results indicate that KLF8 stabilizes b-catenin protein in
cytoplasm and nucleus but not increased the transcription of b-
catenin gene.
Expression of KLF8 Correlates with Progressed HCC
We then detected the clinicopathological correlation of KLF8
positive or/and cytoplasm and nuclear b-catenin accumulation in
the 65 HCC samples. Expression of KLF8 was detected in 25%
(2/8) of Stage I HCC samples, 61.9% (13/21) of Stage II HCC
samples, 84.61% (22/26) Stage III HCC samples, and 100% (10/
10) Stage IV HCC samples (Fig. 1E), which showed expression of
KLF8 positively correlates with progressed HCC. Although
cytoplasm and nuclear b-catenin accumulation did not show
significant correlations with progressed HCC (50% (4/8) of Stage I
HCC samples, 61.9% (13/21) of Stage II HCC samples, 80.77%
(21/26) Stage III HCC samples, and 80% (8/10) Stage IV HCC
samples), expression of KLF8 plus cytoplasm and nuclear b-
catenin accumulation showed positive correlations with progressed
HCC (12.5% (1/8) of Stage I HCC samples, 52.38% (11/21) of
Stage II HCC samples, 73.08% (19/26) Stage III HCC samples,
and 80% (8/10) Stage IV HCC samples, Fig. 1E ).
Figure 1. Relative expression of KLF8 and b–catenin in HCC. (A) Immunohistochemical staining of KLF8 and b-catenin in continuous sections
of HCC tissues. Results are representative of at least ten separate experiments. (B) Relationships of the KLF8 antigens with cytoplasmic and nucleus b–
catenin, in tissue specimens of HCC. Pearson’s Chi-Square test was used for statistical analysis. (C) KLF8 induced b–catenin cytoplasmic and nucleus
accumulation in HepG cells. Control pCMV-tag5a vector or pCMV-tag5a/KLF8 plasmid was transfected into HepG2 cells, cell lysates were then
analyzed with antibodies. (D) KLF8 did not change mRNA level of b–catenin by qRT-PCR assay. (E) The clinicopathological correlation of KLF8 or/and
cytoplasm and nuclear accumulation in HCC samples. *, p,0.05, **, p,0.01.
doi:10.1371/journal.pone.0039668.g001
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Expression of KLF8
We next asked whether KLF8 was regulated by Wnt/b-catenin
signaling pathway. Wnt3a conditioned medium was used to
activate Wnt/b-catenin signaling pathway. Compared with
control medium, the cytoplasmic b-catenin in HepG2 cells treated
with Wnt3a conditioned medium was dramatically increased
(Fig. 2A), which demonstrated Wnt/b-catenin signaling pathway
was activated. By western blotting assay, we then found that KLF8
protein was increased along with activation of Wnt/b-catenin
signaling pathway (Fig. 2A). Using qRT-PCR assay, we found that
the mRNA level of KLF8 was also up-regulated by Wnt3a
conditioned medium (Fig. 2B). These results indicate KLF8 is a
Wnt/b-catenin signaling target gene.
KLF8 Induces Activation of Wnt/b-catenin Signaling
Pathway
We next explored whether KLF8 affect Wnt/b-catenin
signaling pathway. Luciferase reporter assay was employed here.
HepG2 cells were co-transfected with a plasmid encoding the
TCF4 binding sites luciferase reporter (TOP-Flash) or its control
reportor (FOP-Flash) and the system control plasmid encoding the
b-galactosidase reporter. The results showed that, ectopic expres-
sion of KLF8 increased TOP-Flash activity no matter with or
without Wnt3a conditioned medium, but not FOP-Flash activity
(Fig. 2C). To further test whether KLF8 was necessary for the
activation of Wnt/b-catenin signaling, we knockdown the
expression of KLF8 in HepG2 cells using shRNA when Wnt3a
stimulation. As shown in Fig. 2D, KLF8-shRNA1 and KLF8-
Figure 2. KLF8 is a new Wnt/b–catenin target gene and regulator. (A) KLF8 protein was up-regulated when Wnt3a conditioned medium
added, cytoplasmic b–catenin (Cyto-b–catenin) as Wnt3a signaling positive control and a-tubulin as loading control. (B) KLF8 mRNA level was up-
regulated when Wnt3a conditioned medium added. (C) KLF8 increased TCF-4 promoter activities (TOP flash) with or without Wnt3a conditioned
medium. FOP flash was as negative report gene control. The IB results showed overexpression level of KLF8, a-tubulin as loading control. (D)
Knockdown of KLF8 decreased TCF-4 promoter activities (TOP flash) when Wnt3a conditioned medium added. Fop flash was as negative report gene
control. The IB results showed down-regulated protein level of KLF8 by two shRNA compared to control shRNA (KLF8 shRNA Ctrl), a-tubulin as
loading control. (E) Both mRNA and protein levels of Wnt/b–catenin target gene, c-Myc, cyclin D1 and Axin1, were up-regulated by overexpression of
KLF8. (F) Both mRNA and protein levels of Wnt/b–catenin target gene, c-Myc, cyclin D1 and Axin1, were down-regulated by knockdown of KLF8 with
shRNA1 or shRNA2 compared to control shRNA (KLF8 shRNA Ctrl). *, p,0.05, **, p,0.01.
doi:10.1371/journal.pone.0039668.g002
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shRNA, in the meanwhile, the TOP-Flash but not FOP-Flash was
down-regulated by KLF8-shRNA1 and KLF8-shRNA2, but not
control shRNA.
To further investigate whether KLF8 regulated Wnt/b-catenin
signaling transcription activity, we examined the expression of
Axin1, c-Myc and cyclin D1, which are well characterized
targeting genes of Wnt/b-catenin signaling. Indeed, ectopic
expression of KLF8 triggered mRNA and protein expression of
Axin1, c-Myc and cyclin D1 in HepG2 cells (Fig. 2E), whereas
knockdown of KLF8 attenuated their expression in HepG2 cells
stimulated with Wnt3a conditioned medium (Fig. 2F). These
results clearly indicate that KLF8 participate and is necessary in
Wnt/b-catenin signaling pathway for inducing TCF-4 transcrip-
tion activation, leading to the expression of the Wnt targeting
genes, Axin1, c-Myc and cyclin D1.
KLF8 Recuits P300 to b-catenin/TCF4 Transcription
Complex
To investigate how KLF8 regulated Wnt/b-catenin signaling
pathway, we first explored whether KLF8 binded with b-catenin.
Using co-immunoprecipitation (co-IP) assay, we found that b-
catenin could bind with KLF8 in HepG2 cells treated with Wnt3a
conditioned medium (Fig. 3A). Importantly, TCF4 was also
detected in the co-IP complex, which indicated that KLF8 binded
with b-catenin/TCF4 transcription complex. P300 is needed in b-
catenin/TCF4 transcription complex activation and also binds
with KLF8 [15,16], we thus suspected whether KLF8 recruits
P300 to b-catenin/TCF4 transcription complex. Indeed, as shown
in Fig. 3B, b-catenin binded more P300 when KLF8 was
overexpressed in HepG2 cells.
b-catenin Knockdown Inhibits Proliferation of HepG2 and
Hep3B Cells Induced by KLF8 Overexpression
Others’ [13] and our results showed that ectopic expression of
KLF8 increased cell proliferation in HepG2 cells (Fig. 4B). To test
whether the mechanism that KLF8 regulating Wnt/b-catenin
signaling pathway played roles in cell proliferation, we down-
regulated the expression of b-catenin in KLF8-overexpressed
HepG2 cells using shRNA. Compared to control shRNA, b-
catenin-shRNA decreased expression of b-catenin (Fig. 4A), and
inhibited the proliferation of KLF8-overexpressed HepG2 cells
using MTT assay (Fig. 4B). To further conform the functional role
of KLF8/b-catenin in HCC cells, we did the same assay using
another HCC cell line Hep3B. As shown in Fig. 4C and 4D,
ectopic expression of KLF8 increased Hep3B cells proliferation, b-
catenin-shRNA decreased expression of b-catenin and inhibited
the proliferation of KLF8-overexpressed Hep3B cells using MTT
assay. These results demonstrated that KLF8 regulate HCC cells
proliferation through regulating Wnt/b-catenin signaling path-
way.
Discussion
In this report, we showed that KLF8 is a novel targeted gene
and regulator in canonical Wnt/b-catenin signaling pathway and
this finding is possibly clinically relevant. We identified that KLF8
stabilizes b-catenin, binds with and recruits p300 to b-catenin/
TCF4 transcription complex, and activates Wnt/b-catenin target
genes transcription. In the meanwhile, activation of Wnt/b-
catenin signaling pathway up-regulates both mRNA and protein
level of KLF8. Knockdown of b-catenin rescued the phenotype of
overexpressed KLF8 HepG2 and Hep3B cells showed that the
crosstalk between KLF8 and Wnt/b-catenin signaling pathway
plays essential roles in HCC cells proliferation. More importantly,
we showed that the aberrant overexpression of KLF8 is strongly
correlated to the aberrant nucleus accumulation of b-catenin in
human HCC samples, which positively correlates with progressed
HCC.
The three major Wnt signaling pathways are involved in almost
every aspect of embryonic development and in adult tissue
homeostasis. The canonical Wnt/b-catenin signaling pathway
governs cell proliferation, differentiation, migration, and invasion.
It centers around b-catenin, which binds to TCF/LEF transcrip-
tion factors and leads to the target genes transcription. In the
inactive state, the cytoplasmic b-catenin is continuously degraded.
When stimulated by Wnt ligand, b-catenin escapes the degrada-
tion, accumulates in the nucleus, binds with TCF transcription
complex and induces Wnt target genes expression [1–3]. Our
study showed that KLF8 is induced by Wnt3a conditioned
medium, in the meanwhile KLF8 stabilizes b-catenin in cell
cytoplasm and nucleus, enhances Wnt/b-catenin signaling tran-
scription activation. However, the total protein and mRNA level
of b-catenin did not change under KLF8 overexpression. These
results indicated that KLF8 maybe work on destroying GSK3b/
APC/CKIa degradation complex or/and facilitating b-catenin
transfer into nucleus. The further studies are needed to
demonstrate these hypothesises. Our results also showed that
KLF8 binds with TCF4/b-catenin transcription complex, howev-
er, whether KLF8 directly binds with b-catenin or/and TCF4,
Figure 3. KLF8 recruits P300 to b-catenin/TCF4 transcription complex. (A) KLF8 binding to b-catenin and TCF4. KLF8 was
immunoprecipitated from the cell lysates when Wnt3a conditioned medium added, followed by immunoblotting with the antibodies to b-catenin,
TCF4 and KLF8. rIgG as immunoprecipitation negative control antibody. Samples loading control were shown (2% input). (B) KLF8 increase P300
binding to b-catenin. b-catenin was immunoprecipitated from the cell lysates transfected with KLF8 or control vector when Wnt3a conditioned
medium added, followed by immunoblotting with the antibodies to KLF8 and b-catenin. Samples loading control were shown (2% input).
doi:10.1371/journal.pone.0039668.g003
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still needed to be studied further.
As a transcription factor, KLF8 can negatively regulate the
globin and E-cadherin genes through contacting with the C-
terminal Binding Protein (CtBP) corepressor, and positively
regulate cyclinD1 genes by recruitment of the p300 or p300/
CBP associated factor(PCAF) co-activator of the histone acetylase
family [9,14,15]. Histone acetylase p300 is also needed in TCF 4/
b-catenin complex for their transcription activation [16]. Our
results showed that KLF8 activates Wnt/b-catenin signaling
pathway due to the recruitment of p300 to the b-catenin/TCF
complex. Both Wnt/b-catenin signaling pathway and KLF8 can
regulate cylinD1 expression [1,9]. In our system, KLF8 was
needed in regulating cyclin D1 gene when Wnt3a conditioned
medium added. Since KLF8 can directly bind with the promoter
of cyclin D1 [9], there is a possibility that KLF8 may help the b-
catenin/TCF transcription complex binding to cyclin D1
promoter. Further studies are needed to explore this question.
HCC is the top 5 common malignant tumors and third cause of
cancer-related death [17]. The molecular mechanisms that
contribute to tumor initiation or progression of HCC are poorly
understood. Our study showed a novel crosstalk between KLF8
and Wnt/b-catenin signaling pathway, which plays important
roles in HCC cells proliferation, furthermore, co-overexpression of
KLF8 and b-catenin in human HCC samples indicated that
KLF8-Wnt/b-catenin signaling pathway may provide novel
reasoning for therapy of HCC.
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